Brenda Lerner

Research Associate Professor

Health Promotion and Disease Prevention


Phone: 305-456-2967

Email: lernerb@fiu.edu

Focus

HIV Primary and Secondary Prevention and its Relationship to Neurocognitive Health & Dysfunction related to Substance Use and Abuse

Biography

Dr. Brenda Lerner, a licensed psychologist and registered nurse, is a Research Associate Professor in the Department of Health Promotion and Disease Prevention. She has conducted HIV prevention research since 1999 with over twenty years of clinical experience administering cognitive behavioral HIV prevention interventions as well as experience in coordinating and implementing research projects. Dr. Lerner has conducted prevention activities and recruitment among severely mentally ill adults at various community centers for grants that both involved alcohol and HIV involvement and have had direct patient contact with adolescents with psychiatric disorders and drug abuse.

Dr. Lerner is currently involved in research projects involving experimentally induced reduction effects in alcohol consumption on brain cognitive and clinical outcomes and motivation for changing drinking in older persons with HIV infection through contingency management and associated collection of microbiomes as well as a statewide study monitoring barriers to health outcomes. Her last project involved the impact of cannabis use on the neuropsychological functioning of individuals living with HIV/AIDS. She maintains excellent relations with community resources and has great deal of experience coordinating research and research-clinical interface aspects of all the studies she has worked on, and it is her goal to continue success with the projects she is associated, to assist in generating additional studies.

Lab

AIDS Prevention Program

Education

  • Postdoctoral Fellow in Behavioral Medicine, Jackson Memorial Hospital affiliated with The University of Miami, School of Medicine, Miami, FL
  • Intern in Clinical Psychology/Neuropsychology & Community Health, Northwest Ohio Consortium of Professional Training in Psychology, APA – accredited at the time of Internship, Toledo, OH
  • Miami Institute of Psychology of the Caribbean Center of Advanced Studies (currently Carlos Albizu University) Miami, FL, Psy.D. & M.S.
  • University of Illinois at Champaign-Urbana, IL, M.Ed.
  • State University of New York at Buffalo, NY, B.S.N.

Recent Publications

Vidot, D.C., Lerner, B., & Gonzalez, R. (2017). Cannabis use, medication management and adherence among persons living with HIV. AIDS and Behavior, 21(7), 2005-2013. https://doi.org/10.1007/s10461-017-1782-x.

Attonito, J., Dévieux, J.G., Lerner, B.D.G., Hospital, M.M., & Rosenberg, R. (2014). Antiretroviral treatment adherence as a mediating factor between psychosocial variables and HIV viral load. Journal of the Association of Nurses in AIDS Care, 25(6), 626-637. https://doi.org/10.1016/j.jana.2014.08.001

Attonito, J., Dévieux, J.G., Lerner, B.D., Hospital, M.M., & Rosenberg, R. (2014). Exploring substance use and HIV treatment factors associated with neurocognitive impairment among people living with HIV/AIDS. Frontiers in Public Health, 2,105. https://doi.org/ 10.3389/fpubh.2014.00105

Malow, R.M., Dévieux, J.G., Stein, J.A., Rosenberg, R., Lerner, B.G., Attonito, J., & Villaba, K. (2012).  Neurological function, information-motivation-behavioral skills factors, and risk behaviors among HIV-positive alcohol users. AIDS and Behavior, 16(8), 2297-2308. https://doi.org/10.1007/s10461-012-0246-6

Malow, R.M., McMahon, R., Dévieux, J., Rosenberg, R., Frankel, A., Bryant, V., Lerner, B., & Miguez, M. J. (2011). Cognitive behavioral HIV risk reduction in those receiving psychiatric treatment: A clinical trial. AIDS and Behavior, 16(5), 1192-1202. https://doi.org/10.1007/s10461-011-0104-y

Dévieux, J.G., Malow, R.M., Lerner, B.G., Dyer, J., Baptista, L., Lucenko, B., & Kalichman, S. (2007). Triple jeopardy for HIV: Substance using severely mentally ill adults. Journal of Prevention & Intervention in the Community, 33(1-2), 5-18. Note: Also simultaneously published as (2006) HIV: Issues with Mental Health and Illness (pp.1-4). Blank, M.B. & Eisenberg, M.M. (Ed.). New York: Haworth. 

Research Support

Associated with current grants:

"Addressing health disparities in engagement, retention, and utilization of PrEP among women of color (WOC) in South Florida." Funded by RCMI. Principal Investigator: Eric F. Wagner; Supplement Study Principal Investigator: Jessy G. Dévieux, Ph.D. Role: Co-Investigator

“Southern HIV and Alcohol Research Consortium Administrative and Research Support Core (SHARC/The Florida Cohort).” Funded by NIAAA. Principal Investigators: Robert Cook, M.D., Local Principal Investigator: Jessy G. Dévieux, Ph.D. Role: Co-Investigator

“Health Outcomes and Cognitive Effects of Marijuana Use Among Persons Living with HIV/AIDS” (The MAPLE Study).” Funded by NIDA. Principal Investigator: Robert Cook, M.D., Local Principal Investigator: Gladys Ibañez, Ph.D. Role: Co-Investigator

“A Mind-Body Intervention to reduce symptoms among people aging with HIV (The GEM Study).” Funded by NIH/National Center for Complementary and Integrative Health (NCCIH). Principal Investigator: Gladys Ibañez, Ph.D.  Role: Co-Investigator

Previously funded grants:

“Effects Of Experimentally-Induced Reductions In Alcohol Consumption On Brain Cognitive and Clinical Outcomes, And Motivation For Changing Drinking In Older Persons with HIV Infection (The 30 Challenge)" and, “Alcohol Associated Comorbidities And Microbiome Evaluation In HIV (ACME HIV-Substudy>Currently Stand Alone).” Funded by NIAAA. Principal Investigators: Robert Cook, M.D., MPH, Jessy G. Dévieux, Ph.D., Varan Govind, Ph.D., & Allan E. Rodriquez, M.D.

“Alzheimer's-gut-microbiome grant supplement for MAPLE Study.” Funded by NIDA. Principal Investigator: Robert Cook, M.D., Local Principal Investigator: Gladys Ibañez, Ph.D.  

“The Impact of Cannabis Use on the Neuropsychological Functioning of Individuals with HIV/AIDS.” Funded by NIDA. Principal Investigator: Raul Gonzalez, Ph.D.

“Intervening With HIV+ Alcohol Abusers: Influence of Neuro-Behavioral Factors.” Funded by NIAAA. Principal Investigator: Robert M. Malow, Ph.D., Co-PI: Jessy G. Dévieux, Ph.D.

 “Multi-Level HIV Prevention for Pregnant Drug Users.” Funded by NIDA. Principal Investigator: Robert M. Malow, Ph.D., Co-PI:  Jessy G. Dévieux, Ph.D.

 “HIV Prevention Groups for Alcohol and Drug (AOD) Using Severely Mentally Ill (SMI) Women.” Funded by NIDA. Principal Investigator:  Robert M. Malow, Ph.D., Co-PI:  Jessy G. Dévieux, Ph.D.

 “HIV Prevention for Adolescents: Research to Practice.”  Funded by NIDA.  Principal Investigator: Robert Malow, Ph.D., Co-PI: Jessy G. Dévieux, Ph.D. 

“Cognitive Behavioral Treatment of HIV+ Drug Abusers.” Funded by NIDA. Principal Investigator: Dr. Robert Malow; Investigators: Jessy G. Dévieux, Ph.D., Michael Antoni, Ph.D., Nancy Klimas, M.D., Neil Schneiderman, Ph.D., J. Bryan Page, Ph.D.

 “Reducing HIV Risk among Mentally Ill Alcohol Abusers” Funded by NIAAA. Principal Investigator: Robert Malow, Ph.D., Co-PI: Jessy G. Dévieux, Ph.D. 

“Reducing HIV Risk in Drug Abusing Youth.” Funded by NIDA. Principal Investigator: Jessy G. Dévieux, Ph.D., Co-PI:  Robert M. Malow, Ph.D.

“Risk Reduction in HIV+/HIV- Alcohol Abusing Youths.” Funded by NIAAA. Principal Investigator: Jessy G. Dévieux, Ph.D., Co-PI: Robert Malow, Ph.D.